ArticleAnnals of translational medicine2015

Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.

Mehdi Rashighi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.